75 related articles for article (PubMed ID: 1803860)
21. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
22. Lack of effect of hematopoietic growth factors on human breast epithelial cell growth in serum-free primary culture.
Emerman JT; Eaves CJ
Bone Marrow Transplant; 1994 Mar; 13(3):285-91. PubMed ID: 7515301
[TBL] [Abstract][Full Text] [Related]
23. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
24. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
Lin Y; Wang SM; Huang RP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
26. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
27. The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer.
Asgeirsson KS; Olafsdóttir K; Jónasson JG; Ogmundsdóttir HM
Cytokine; 1998 Sep; 10(9):720-8. PubMed ID: 9770334
[TBL] [Abstract][Full Text] [Related]
28. Reduced expression of c-erbB2 gene product in human mammary carcinoma SK-BR-3 cells treated with interferon-gamma and tumor necrosis factor-alpha.
Kumar R; Mendelsohn J
Anticancer Res; 1994; 14(3A):1001-8. PubMed ID: 7915505
[TBL] [Abstract][Full Text] [Related]
29. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines.
Morinaga Y; Suzuki H; Takatsuki F; Akiyama Y; Taniyama T; Matsushima K; Onozaki K
J Immunol; 1989 Dec; 143(11):3538-42. PubMed ID: 2584706
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
[TBL] [Abstract][Full Text] [Related]
31. Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.
Shen WH; Zhou JH; Broussard SR; Freund GG; Dantzer R; Kelley KW
Cancer Res; 2002 Aug; 62(16):4746-56. PubMed ID: 12183434
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine.
Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF
Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945
[TBL] [Abstract][Full Text] [Related]
33. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
Rohrer JW; Barsoum AL; Dyess DL; Tucker JA; Coggin JH
J Immunol; 1999 Jun; 162(11):6880-92. PubMed ID: 10352310
[TBL] [Abstract][Full Text] [Related]
34. IL-6 and IFN-gamma regulation of IL-10 production by human colon carcinoma cells.
Suzuki S; Mita S; Kamohara H; Sakamoto K; Ishiko T; Ogawa M
Int J Oncol; 2001 Mar; 18(3):581-6. PubMed ID: 11179490
[TBL] [Abstract][Full Text] [Related]
35. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA.
Oh JW; Revel M; Chebath J
Cytokine; 1996 May; 8(5):401-9. PubMed ID: 8726669
[TBL] [Abstract][Full Text] [Related]
36. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.
Wieder R; Fenig E; Wang H; Wang Q; Paglin S; Menzel T; Gabrilove J; Fuks Z; Yahalom J
J Cell Physiol; 1998 Dec; 177(3):411-25. PubMed ID: 9808150
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.
Okamoto M; Lee C; Oyasu R
Cancer Res; 1997 Jan; 57(1):141-6. PubMed ID: 8988055
[TBL] [Abstract][Full Text] [Related]
40. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
Gooch JL; Herrera RE; Yee D
Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]